Division of Gastroenterology, Department of Medicine, The Arthur M. Schoen MD Chair in Gastroenterology, Hepatology, and Nutrition, University of Louisville, Louisville, KY, United States.
Division of Gastroenterology, Department of Medicine, The Arthur M. Schoen MD Chair in Gastroenterology, Hepatology, and Nutrition, University of Louisville, Louisville, KY, United States.
J Gastrointest Surg. 2024 Nov;28(11):1752-1761. doi: 10.1016/j.gassur.2024.08.003. Epub 2024 Aug 9.
Postsurgical gastroparesis, resulting from surgical interventions on the stomach or vagal nerve injury, poses significant clinical challenges with patients presenting symptoms such as nausea, vomiting, and abdominal pain. Although gastric electrical stimulation (GES) offers potential relief, its efficacy in refractory postsurgical gastroparesis requires further examination. This study evaluated the clinical response to GES in patients with refractory postsurgical gastroparesis.
A retrospective study was conducted across 2 study sites, involving 185 patients with drug-refractory postsurgical gastroparesis who underwent both temporary and permanent GES placements. Patients were categorized based on their surgical history: bariatric surgery, Nissen fundoplication, and others. The impact of GES was evaluated using Food and Drug Administration-compliant patient-reported outcomes scores and other relevant clinical metrics at baseline, after temporary GES placement, and 6 months after permanent GES placement. All 3 groups were also analyzed by the symptom improved group vs the unimproved group at baseline and 6 months after GES placement.
After GES implantation, all patient groups significantly improved upper gastrointestinal symptoms. The bariatric surgery group and Nissen fundoplication group specifically identified anorexia as the most severe symptom after GES after temporary GES placement among 3 groups (2.5 [0.4-3.5] and 1.5 [0.0-2.5], respectively). Nissen fundoplication patients had the highest score of anorexia among the 3 groups 6 months after GES (3.0 [2.0-3.5], P = .018). Despite these improvements, GES did not enhance gastric emptying test results. Symptomatic improvements were notably significant in patients who initially reported higher symptom severity than those who did not.
GES shows promise in alleviating symptoms of refractory postsurgical gastroparesis, particularly in those with severe initial symptoms. However, its impact on gastric emptying remains inconclusive. Further research is needed to establish GES as a standard treatment for postsurgical gastroparesis.
术后胃轻瘫是由于胃或迷走神经损伤的手术干预引起的,患者会出现恶心、呕吐和腹痛等症状,这给临床带来了巨大挑战。尽管胃电刺激(GES)提供了潜在的缓解效果,但它在难治性术后胃轻瘫中的疗效仍需进一步研究。本研究评估了难治性术后胃轻瘫患者接受 GES 的临床反应。
在两个研究地点进行了一项回顾性研究,共纳入 185 例药物难治性术后胃轻瘫患者,他们接受了临时和永久性 GES 植入。根据手术史将患者分为减肥手术、Nissen 胃底折叠术和其他手术。在基线、临时 GES 植入后和永久性 GES 植入后 6 个月,使用符合食品和药物管理局标准的患者报告结局评分和其他相关临床指标评估 GES 的影响。所有 3 组也根据基线和 GES 植入后 6 个月的症状改善组和未改善组进行了分析。
在 GES 植入后,所有患者组的上消化道症状均显著改善。在 3 组中,减肥手术组和 Nissen 胃底折叠术组在临时 GES 植入后,特别指出食欲减退是 GES 后最严重的症状(分别为 2.5 [0.4-3.5] 和 1.5 [0.0-2.5])。在 GES 植入后 6 个月,Nissen 胃底折叠术组患者的食欲减退评分在 3 组中最高(3.0 [2.0-3.5],P =.018)。尽管有这些改善,但 GES 并未改善胃排空试验结果。在初始报告症状严重程度较高的患者中,症状改善显著。
GES 有望缓解难治性术后胃轻瘫的症状,特别是对初始症状严重的患者。然而,其对胃排空的影响仍不确定。需要进一步的研究来确立 GES 作为术后胃轻瘫的标准治疗方法。